BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33047643)

  • 1. Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature.
    Sharifinejad N; Azizi G; Behniafard N; Zaki-Dizaji M; Jamee M; Yazdani R; Abolhassani H; Aghamohammadi A
    Immunol Invest; 2022 Feb; 51(2):331-342. PubMed ID: 33047643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
    Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
    Front Immunol; 2018; 9():2400. PubMed ID: 30386345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
    Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
    López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
    Front Immunol; 2021; 12():671755. PubMed ID: 34447369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans.
    Kuehn HS; Niemela JE; Rangel-Santos A; Zhang M; Pittaluga S; Stoddard JL; Hussey AA; Evbuomwan MO; Priel DA; Kuhns DB; Park CL; Fleisher TA; Uzel G; Oliveira JB
    Blood; 2013 Apr; 121(16):3117-25. PubMed ID: 23430113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.
    Gu H; Chen Z; Ma J; Wang J; Zhang R; Wu R; Wang T
    Int J Immunopathol Pharmacol; 2021; 35():20587384211025934. PubMed ID: 34187243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding spectrum of the autoimmune lymphoproliferative syndromes.
    Oliveira JB
    Curr Opin Pediatr; 2013 Dec; 25(6):722-9. PubMed ID: 24240292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
    Failing C; Blase JR; Walkovich K
    Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
    Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
    J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide Responsive Beige-like Anchor Protein Deficiency in a Patient with Autoimmune Lymphoproliferative Syndrome-like Disease Phenotype: A Case Report and Literature Review.
    Fetyan S; Sakrani NF; Yassin F; Abdallah MF; Elzein N; Azizi G; ElGhazali G
    Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):219-227. PubMed ID: 35490276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.
    Nomura K; Kanegane H; Otsubo K; Wakiguchi H; Noda Y; Kasahara Y; Miyawaki T
    Int J Hematol; 2011 Jun; 93(6):760-764. PubMed ID: 21626105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
    Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key diagnostic markers for autoimmune lymphoproliferative syndrome with molecular genetic diagnosis.
    Molnár E; Radwan N; Kovács G; Andrikovics H; Henriquez F; Zarafov A; Hayman M; Linzner D; Thrasher AJ; Buckland M; Burns SO; Gilmour KC
    Blood; 2020 Oct; 136(17):1933-1945. PubMed ID: 32599613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
    Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
    J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
    Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS).
    Lambert MP
    Expert Rev Clin Immunol; 2021 Nov; 17(11):1163-1173. PubMed ID: 34503378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Seif AE; Grupp SA
    Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.